search again

Ranibizumab (Susvimo) Sustained-Release Implant

Nationwide rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $79 · 10th–90th $78$1260%50%10th90th$79Professionalmedian $79 · 10th–90th $78$810%50%10th90th$79$50.0$200.0$1.0K$5.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$77.62
Median
$79.43
Typical High
$95.50
Aetna
Setting
Professional
Modifier
Global
Typical Low
$77.62
Median
$79.43
Typical High
$81.28
United
Setting
Facility
Modifier
Global
Typical Low
$1,258.93
Median
$1,258.93
Typical High
$1,258.93
United
Setting
Professional
Modifier
Global
Typical Low
$95.50
Median
$95.50
Typical High
$95.50